K. Wilner
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
-
- Lung Cancer Research Studies
- Drug Transport and Resistance Mechanisms
Papers in
-
- Lung Cancer Treatments and Mutations 10
- Lung Cancer Diagnosis and Treatment 4
- Oncology 9
- Lung Cancer Research Studies 3
- Co-authors
- Benjamin Solomon (6 shared papers)A. Shaw (1 shared paper)Xinjie Lin (1 shared paper)M. R. Bleavins (1 shared paper)John A. Williams (1 shared paper)Kanako Sekiguchi (1 shared paper)May Garrett (1 shared paper)I-J Jang (1 shared paper)
- Journals
- British Journal of Clinical Pharmacology (9 papers)Annals of Oncology (5 papers)Clinical Pharmacology & Therapeutics (3 papers)Journal of Thoracic Oncology (2 papers)European Psychiatry (1 paper)
- Partner nations
- United StatesSouth KoreaItaly
In The Last Decade
K. Wilner
24 papers receiving 490 citations
Peers
Comparison fields: 5 of 63
- Pharmacology 107
- Oncology 149
- Psychiatry and Mental health 78
- Pulmonary and Respiratory Medicine 137
- Hepatology 30
Countries citing papers authored by K. Wilner
This map shows the geographic impact of K. Wilner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Wilner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Wilner more than expected).
Fields of papers citing papers by K. Wilner
This network shows the impact of papers produced by K. Wilner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Wilner. The network helps show where K. Wilner may publish in the future.
Co-authors
The 25 scholars most cited alongside K. Wilner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 190 | |
| 2 | 2013 | 73 | |
| 3 | 2000 | 36 | |
| 4 | 1997 | 32 | |
| 5 | 2000 | 27 | |
| 6 | 2000 | 24 | |
| 7 | 2010 | 20 | |
| 8 | 2012 | 16 | |
| 9 | 2016 | 14 | |
| 10 | 1995 | 12 | |
| 11 | 2016 | 12 | |
| 12 | 1995 | 10 | |
| 13 | 2012 | 9 | |
| 14 | 2011 | 8 | |
| 15 | 1995 | 7 | |
| 16 | 1995 | 7 | |
| 17 | The pharmacokinetics of CP-88,059 in healthy male volunteers following oral and intravenous administration | 1994 | 6 |
| 18 | Updated Antitumor Activity of Crizotinib in Patients with MET Exon 14-Altered Advanced Non-Small Cell Lung Cancer | 2018 | 6 |
| 19 | 2012 | 5 | |
| 20 | 1995 | 4 |
About K. Wilner
K. Wilner is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Pediatrics, Perinatology and Child Health, Pharmacology and Molecular Biology, having authored 24 papers that have together received 528 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (10 papers), Pharmacogenetics and Drug Metabolism (5 papers), Lung Cancer Diagnosis and Treatment (4 papers), Pharmacological Effects and Toxicity Studies (4 papers), Drug-Induced Hepatotoxicity and Protection (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers), Lung Cancer Research Studies (3 papers) and Pharmaceutical studies and practices (3 papers). The work is most often cited by research in Pharmacology (107 citations), Oncology (149 citations), Psychiatry and Mental health (78 citations), Pulmonary and Respiratory Medicine (137 citations) and Hepatology (30 citations). K. Wilner has collaborated with scholars based in United States, South Korea and Italy. Frequent co-authors include Benjamin Solomon, A. Shaw, Xinjie Lin, M. R. Bleavins, John A. Williams, Kanako Sekiguchi, May Garrett, I-J Jang, Yasushi Fujio and Junichi Azuma. Their work appears in journals such as British Journal of Clinical Pharmacology, Annals of Oncology, Clinical Pharmacology & Therapeutics, Journal of Thoracic Oncology and European Psychiatry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.